BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 18, 2008
View Archived Issues
Cytos Signs $139M Deal with Pfizer for Immunodrug Vaccines
As three of its own Immunodrug vaccine candidates advance through clinical trials, Cytos Biotechnology AG signed a CHF150 (US$139 million) technology deal with Pfizer Inc.'s vaccine unit. (BioWorld Today)
Read More
Aiming for Profitability, Nanogen Signs Merger Deal with Elitech
Read More
Oxford BioMedica Rejects 'Surprise' GeneThera Offer
Read More
Prestwick's Xenazine Gains First U.S. OK for Huntington's
Read More
Metronomic Dosing Successful in NCI Prostate Cancer Vaccine Trial
Read More
Clinic Roundup
Read More
Other News To Note
Read More